Skip to main content
Top
Published in: Inflammopharmacology 4/2023

07-05-2023 | Arthritis | Review

Mechanism of action of quercetin in rheumatoid arthritis models: meta-analysis and systematic review of animal studies

Authors: Xinru Liu, Tao Tao, Huan Yao, Huilan Zheng, Fuming Wang, Yongxiang Gao

Published in: Inflammopharmacology | Issue 4/2023

Login to get access

Abstract

Quercetin, a typical flavonoid derived from a common natural plant, has multiple biological activities. Previous research in animal models has demonstrated the effectiveness of quercetin in treating rheumatoid arthritis (RA). The pharmacological effects and probable mechanisms of quercetin were evaluated in this study. Three databases, PubMed, Web of Science, and Embase, were searched for relevant studies from the creation of the databases to November 2022. Methodological quality was assessed using the SYRCLE risk of bias tool. STATA 15.1 was used to perform the statistical analysis. This research included 17 studies involving 251 animals. The results indicated that quercetin was able to reduce arthritis scores, paw swelling, histopathological scores, interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-17 (IL-17), tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1), C-reactive protein (CRP), malondialdehyde (MDA), reactive oxygen species (ROS), thiobarbituric acid reactive substances (TBARS), nuclear factor kappa B (NF-kB) and increase interleukin-10 (IL-10), catalase (CAT), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), glutathione (GSH), and heme oxygenase-1 (HO-1). These may be related to quercetin's potential anti-inflammatory, anti-oxidative stress, and osteoprotective properties. However, more high-quality animal studies are needed to assess the effect of quercetin on RA. Additionally, the safety of quercetin requires further confirmation. Given the importance of the active ingredient, dose selection and the improvement of quercetin's bioavailability remain to be explored.
Appendix
Available only for authorised users
Literature
go back to reference Amalraj A, Varma K, Jacob J et al (2017) A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Med Food 20(10):1022–1030. https://doi.org/10.1089/jmf.2017.3930CrossRefPubMed Amalraj A, Varma K, Jacob J et al (2017) A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Med Food 20(10):1022–1030. https://​doi.​org/​10.​1089/​jmf.​2017.​3930CrossRefPubMed
go back to reference Ansari MM, Neha, Khan HA (2014) Quercetin alleviate oxidative stress and inflammation through upregulation of antioxidant machinery and down-regulation of COX2 and NF-κB expression in collagen induced rheumatoid arthritis. Int J Drug Dev Res 6(1):215–230 Ansari MM, Neha, Khan HA (2014) Quercetin alleviate oxidative stress and inflammation through upregulation of antioxidant machinery and down-regulation of COX2 and NF-κB expression in collagen induced rheumatoid arthritis. Int J Drug Dev Res 6(1):215–230
go back to reference Chis IC, Baltaru D, Clichici S, Oniga O, Cojocaru I, Nastasa C (2018) The effects of a 5-chromene-yl-thiazolidin-2,4-dione derivative in alleviating oxidative stress in adjuvant-induced arthritis. Rev Chim 69(9):2361–2365CrossRef Chis IC, Baltaru D, Clichici S, Oniga O, Cojocaru I, Nastasa C (2018) The effects of a 5-chromene-yl-thiazolidin-2,4-dione derivative in alleviating oxidative stress in adjuvant-induced arthritis. Rev Chim 69(9):2361–2365CrossRef
go back to reference Haleagrahara N, Hodgson K, Miranda-Hernandez S, Hughes S, Kulur AB, Ketheesan N (2018) Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis. Inflammopharmacology 26(5):1219–1232. https://doi.org/10.1007/s10787-018-0464-2CrossRefPubMed Haleagrahara N, Hodgson K, Miranda-Hernandez S, Hughes S, Kulur AB, Ketheesan N (2018) Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis. Inflammopharmacology 26(5):1219–1232. https://​doi.​org/​10.​1007/​s10787-018-0464-2CrossRefPubMed
go back to reference Knight JA (2000) Review: free radicals, antioxidants, and the immune system. Ann Clin Lab Sci 30(2):145–158PubMed Knight JA (2000) Review: free radicals, antioxidants, and the immune system. Ann Clin Lab Sci 30(2):145–158PubMed
go back to reference Wang T, Li Z (2020) Diagnosis and treatment of rheumatoid arthritis. Chin J General Practice 18(02):170–171 Wang T, Li Z (2020) Diagnosis and treatment of rheumatoid arthritis. Chin J General Practice 18(02):170–171
go back to reference Wang W, Dou R, Huang J, Bi Z, Ma C, Pang W (2023) The relationship between the blood uric acid, monocyte chemoattractant protein-1 and cystatin C and the intracranial artery stenosis in young stroke patients. J Pract Hosp Clin 20(1):23–26 Wang W, Dou R, Huang J, Bi Z, Ma C, Pang W (2023) The relationship between the blood uric acid, monocyte chemoattractant protein-1 and cystatin C and the intracranial artery stenosis in young stroke patients. J Pract Hosp Clin 20(1):23–26
go back to reference Yoshihara Y, Yamada H (2007) Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis. Clin Calcium 17(4):500–508PubMed Yoshihara Y, Yamada H (2007) Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis. Clin Calcium 17(4):500–508PubMed
Metadata
Title
Mechanism of action of quercetin in rheumatoid arthritis models: meta-analysis and systematic review of animal studies
Authors
Xinru Liu
Tao Tao
Huan Yao
Huilan Zheng
Fuming Wang
Yongxiang Gao
Publication date
07-05-2023
Publisher
Springer International Publishing
Published in
Inflammopharmacology / Issue 4/2023
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-023-01196-y

Other articles of this Issue 4/2023

Inflammopharmacology 4/2023 Go to the issue